Company news
Opthea Limited news in 2022
Opthea Limited's news releases, calls and decks from 2022, newest first.
Chairmans Address to Shareholders
November 15, 2022
Completion of Share Purchase Plan
September 26, 2022
Opthea reports Fiscal Year 2022 Results and Highlights
August 29, 2022
Opthea Appendix 4E and Annual Report 2022
August 29, 2022
Opthea Share Purchase Plan
August 24, 2022
Form 6-K with SEC
August 15, 2022
Opthea Successfully Closes Well Supported US$90m Financing
August 15, 2022
Opthea secures up to US$170m in non-dilutive financing
August 15, 2022
Opthea Data for OPT-302 for PCV presented at ARVO 2022
May 5, 2022
Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
May 1, 2022
S&P DJI Announces March 2022 Quarterly Rebalance
March 4, 2022
Opthea Half Year Report and Accounts
February 27, 2022
Angiogenesis 2022 -Prof Cheung presentation of PCV data
February 13, 2022
Opthea announces establishment of ATM Equity Program
February 1, 2022
Opthea Receives A$6.6m R&D Tax Incentive
January 24, 2022
Decks in 2022
- Angiogenesis, Exudation & Degeneration 2022
Conference · 20 slides · Feb 14, 2022